Double Digit NASDAQ Stock Winners: ZIVO, PLAT, AEHR
7:40 am Monday, September 27th, 2021
Following are major stock gainers on Nasdaq in Friday’s trading session:
ZIVO Bioscience, Inc. (NASDAQ:ZIVO) was the active stock gainer on Friday and soared 58% to $5. despite a lack of news concerning the company. Instead, it looks like we’ve got another classic case of a penny stock being pushed higher by retail traders. These traders look for cheap stocks to pump higher so that they can dump their shares at a higher price.
Backing up that idea today is the heavy trading ZIVO stock is undergoing. As of this writing, more than 53 million shares of the stock have changed hands. To put that in perspective, the company’s daily average trading volume is closer to 2.2 million shares.
Paltalk, Inc. (NASDAQ:PALT) stock surged 37% to $4.01. Paltalk, Inc., together with its subsidiaries, operates as a communications software provider that develops multimedia social applications and secure communication solutions worldwide. The company offers consumer applications, which include Paltalk, Camfrog, and Tinychat for live video chat; and Vumber, a telecommunications application that enables users to have multiple phone numbers in any area code through which calls can be forwarded to a user’s existing cell phone or land line telephone number.
It also provides technology development and related services; and professional services. The company was formerly known as PeerStream, Inc. and changed its name to Paltalk, Inc. in May 2020. Paltalk, Inc. is based in Jericho, New York.
Aehr Test Systems (NASDAQ:AEHR) moved up 34% to $15.82 after the company reported better-than-expected first-quarter fiscal 2022 results late yesterday. The company’s bookings hit a new record, and management raised its revenue guidance for the full year as a result of the strong quarter. Aehr Test Systems reported net revenue of $5.6 million in the quarter, a 181% jump year over year. Additionally, the company’s bookings reached a record $20.7 million in the quarter. Investors were also impressed that the company’s adjusted (non-GAAP) loss per share of $0.02 was better than Wall Street’s consensus estimate of $0.03.
Aehr’s CEO, Gayn Erickson, talked about the company’s results in a press release, saying, “As we discussed and anticipated last year during the beginning of the COVID-19 pandemic, we have emerged a stronger company, with more production customers, more markets and applications, and higher-value products than we had before the start of the pandemic.”
